RBFOX3 and Stroke: There were significantly more Glut-1/BrdU-positive and NeuN/BrdU-positive cells in the stroke plus SDF-1α-iPS-NPCs transplantation group compared to the sham, stroke only, and stroke plus control iPS-NPCs groups, (Figure 5A-5C).